Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9312149rdf:typepubmed:Citationlld:pubmed
pubmed-article:9312149lifeskim:mentionsumls-concept:C0044602lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C0759310lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C1332711lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:9312149lifeskim:mentionsumls-concept:C1711351lld:lifeskim
pubmed-article:9312149pubmed:issue40lld:pubmed
pubmed-article:9312149pubmed:dateCreated1997-10-22lld:pubmed
pubmed-article:9312149pubmed:abstractTextT cell receptor signaling results both in T cell proliferation and apoptosis. A key enzyme at the intersection of these downstream pathways is phosphatidylinositol 3'-kinase (PI 3-kinase). In a previous report, we showed that the p85alpha subunit of the PI 3-kinase preferentially associated with the CD3-zeta membrane-proximal immunoreceptor tyrosine-based activation motif of the zeta chain (zetaA-ITAM) (Exley, M., Varticovski, L., Peter, M., Sancho, J., and Terhorst, C. (1994) J. Biol. Chem. 269, 15140-15146). Here, we demonstrate that tyrosine phosphorylation of CD3-epsilon can recruit the PI 3-kinase enzyme in a T cell activation-dependent manner. In vivo studies with Jurkat cells stably transfected with a CD8-CD3-epsilon chimera (termed CD8-epsilon) shows that ligation of endogenous CD3-epsilon or CD8-epsilon by specific antibodies induces tyrosine phosphorylation of CD3-epsilon or CD8-epsilon, respectively. Increased tyrosine phosphorylation correlates with increased binding of p85alpha PI 3-kinase and recruitment of PI 3-kinase enzymatic activity to CD3-epsilon or CD8-epsilon proteins. Mutagenesis studies in COS-7 cells, transiently transfected with CD8-epsilon, p85alpha, and Fyn cDNAs in various combinations, show that both Tyr170 and Tyr181 within the CD3-epsilon-ITAM are required for efficient binding of p85alpha PI 3-kinase. Thus, replacement of Tyr170 by Phe (Y170F), or Tyr181 by Phe (Y181F) significantly reduces binding of p85alpha PI 3-kinase, whereas it does not affect binding of Fyn. Further in vitro experiments suggest that a direct binding of the tandem SH2 domains of p85alpha PI 3-kinase to the two phosphorylated tyrosines in a single CD3-epsilon-ITAM may occur. The data also support a model in which a single CD3 subunit can recruit distinct effector molecules by means of TCR-mediated differential ITAM phosphorylation.lld:pubmed
pubmed-article:9312149pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:languageenglld:pubmed
pubmed-article:9312149pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:citationSubsetIMlld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9312149pubmed:statusMEDLINElld:pubmed
pubmed-article:9312149pubmed:monthOctlld:pubmed
pubmed-article:9312149pubmed:issn0021-9258lld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:TerhorstCClld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:SanchoJJlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:HARTM EMElld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:MisraSSlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:MetzgerM HMHlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:ZhengDDlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:VarticovskiLLlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:ExleyMMlld:pubmed
pubmed-article:9312149pubmed:authorpubmed-author:de AósIIlld:pubmed
pubmed-article:9312149pubmed:issnTypePrintlld:pubmed
pubmed-article:9312149pubmed:day3lld:pubmed
pubmed-article:9312149pubmed:volume272lld:pubmed
pubmed-article:9312149pubmed:ownerNLMlld:pubmed
pubmed-article:9312149pubmed:authorsCompleteYlld:pubmed
pubmed-article:9312149pubmed:pagination25310-8lld:pubmed
pubmed-article:9312149pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:meshHeadingpubmed-meshheading:9312149-...lld:pubmed
pubmed-article:9312149pubmed:year1997lld:pubmed
pubmed-article:9312149pubmed:articleTitleTyrosine phosphorylation of the CD3-epsilon subunit of the T cell antigen receptor mediates enhanced association with phosphatidylinositol 3-kinase in Jurkat T cells.lld:pubmed
pubmed-article:9312149pubmed:affiliationInstituto de Parasitología y Biomedicina, Consejo Superior de Investigaciones Científicas, Ventanilla 11, 18001 Granada, Spain.lld:pubmed
pubmed-article:9312149pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9312149pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9312149pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:916entrezgene:pubmedpubmed-article:9312149lld:entrezgene
entrez-gene:5295entrezgene:pubmedpubmed-article:9312149lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:9312149lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9312149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9312149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9312149lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9312149lld:pubmed